Whole exome sequencing in females with autism implicates novel and candidate genes

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2015, Pages 1312-1335

  Butler, Merlin G ^a   Rafi, Syed K ^a   Hossain, Waheeda ^a   Stephan, Dietrich A ^b   Manzardo, Ann M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Autism spectrum disorder; Females; Genetic variants; Whole exome sequencing; X chromosome inactivation

Indexed keywords

ANKYRIN; CADHERIN; GENOMIC DNA;

ADHESION; ADOLESCENT; ARTICLE; AUTISM; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DNA ISOLATION; EXOME; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; LYMPHOBLASTOID CELL LINE; NERVE FUNCTION; NERVE GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEXT GENERATION SEQUENCING; RISK; SCREENING; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME INACTIVATION; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; PRESCHOOL CHILD;

ADOLESCENT; ANKYRINS; AUTISTIC DISORDER; CADHERINS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEUROGENESIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84920911050     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16011312     Document Type: Article

References (110)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; American Psychiatric Association Press: Washington, DC, USA, 2000
2. Johnson, C.P.; Myers, S.M.; The Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007, 120, 1183–1215
3. Lord, C.; Risi, S.; Lambrecht, L.; Cook, E.H., Jr.; Leventhal, B.L.; DiLavore, P.C.; Pickles, A.; Rutter, M. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 2000, 30, 205–223
4. Le Couteur, A., Lord, C., Ruter, M. Autism Diagnostic Interview-Reviewed (ADI-R); Western Psychological Services: Los Angeles, CA, USA, 2003
5. Constantino, J.N.; Davis, S.A.; Todd, R.D.; Schindler, M.K.; Gross, M.M.; Brophy, S.L.; Metzger, L.M.; Shoushtari, C.S.; Splinter, R.; Reich, W. Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. J. Autism Dev. Disord. 2003, 33, 427–433
6. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill. Summ. 2014, 63, 1–21
7. Rapin, I.; Dunn, M. The neurology of autism: Many unanswered questions. Eur. J. Neurol. 1995, 2, 151–162
8. Geschwind, D.H.; Levitt, P. Autism spectrum disorders: Developmental disconnection syndromes. Curr. Opin. Neurobio. 2007, 17, 103–111
9. Butler, M.G.; Dasouki, M.J.; Zhou, X.P.; Talebizadeh, Z.; Brown, M.; Takahashi, T.N.; Miles, J.H.; Wang, C.H.; Stratton, R.; Pilarski, R. et al.Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 2005, 42, 318–321
10. Herman, G.E.; Henninger, N.; Ratliff-Schaub, K.; Pastore, M.; Fitzgerald, S.; McBride, K.L. Genetic testing in autism: How much is enough? Genet. Med. 2007, 9, 268–274
11. Roberts, J.L.; Hovanes, K.; Dasouki, M.; Manzardo, A.M.; Butler, M.G. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene 2014, 535, 70–78
12. Butler MG, Rafi, S.K.; Manzardo, AM. Clinically relevant candidate and known genes for autism spectrum disorders (ASD) with representation on high resolution chromosome ideograms. OA Autism 2014, 2, 5–28
13. Lyon, M.F. X-chromosome inactivation and human genetic disease. Acta Paediatr. 2002, 91, 107–112
14. Plenge, R.M.; Stevenson, R.A.; Lubs, H.A.; Schwartz, C.E.; Willard, H.F. Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am. J. Hum. Genet. 2002, 71, 168–173
15. Talebizadeh, Z.; Bittel, D.C.; Veatch, O.J.; Kibiryeva, N.; Butler, M.G. Brief report: Non-random X chromosome inactivation in females with autism. J. Autism Dev. Disord. 2005, 35, 675–681
16. Buyse, I.M.; Fang, P.; Hoon, K.T.; Amir, R.E.; Zoghbi, H.Y., Roa, B.B. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: Identification of several novel mutations and polymorphisms. Am. J. Hum. Genet. 2000, 67, 1428–1436
17. Maier, E.M.; Kammerer, S.; Muntau, A.C.; Wichers, M.; Braun, A.; Roscher, A.A. Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation. Ann. Neurol. 2002, 52, 683–688
18. Butler, M.G.; Theodoro, M.F.; Bittel, D.C.; Kuipers, P.J.; Driscoll, D.J.; Talebizadeh, Z. X-chromosome inactivation patterns in females with Prader-Willi syndrome. Am. J. Med. Genet. A 2007, 143, 469–475
19. Butler, M.G.; Sturich, J.; Myers, S.E.; Gold, J.A.; Kimonis, V.; Driscoll, D.J. Is gestation in Prader-Willi syndrome affected by the genetic subtype? J. Assist. Reprod. Genet. 2009, 26, 461–466
20. Cassidy, S.B.; Lai, L.W.; Erickson, R.P.; Magnuson, L.; Thomas, E.; Gendron, R.; Herrmann, J. Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy. Am. J. Hum. Genet. 1992, 51, 701–708
21. Allen, R.C.; Zoghbi, H.Y.; Moseley, A.B.; Rosenblatt, H.M.; Belmont, J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with x chromosome inactivation. Am. J. Hum. Genet. 1992, 51, 1229–1239
22. Bittel, D.C.; Theodoro, M.F.; Kibiryeva, N.; Fischer, W.; Talebizadeh, Z.; Butler, M.G. Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J. Med. Genet. 2008, 45, 309–313
23. Bond, J.; Roberts, E.; Mochida, G.H.; Hampshire, D.J.; Scott, S.; Askham, J.M.; Springell, K.; Mahadevan, M.; Crow, Y.J.; Markham, A.F. et al.ASPM is a major determinant of cerebral cortical size. Nat. Genet. 2002, 32, 316–320
24. Vermeulen, M.; Mulder, K.W.; Denissov, S.; Pim Pijnappel, W.W. M.; van Schaik, F.M.A.; Varier, R.A.; Baltissen, M.P.A.; Stunnenberg, H.G.; Mann, M.; Timmers, H.T.M. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007, 131, 58–69
25. Lacy, S.E.; Bonnemann, C.G.; Buzney, E.A., Kunkel, L.M. Identification of FLRT1, FLRT2, and FLRT3: A novel family of transmembrane leucine-rich repeat proteins. Genomics 1999, 62, 417–426
26. Wang, J.; Takeuchi, T.; Yokota, H.; Izumi, T. Novel rabphilin-3-like protein associates with insulin-containing granules in pancreatic beta cells. J. Biol. Chem.1999, 274, 28542–28548
27. Faber, P.W.; Barnes, G.T.; Srinidhi, J.; Chen, J.; Gusella, J.F.; MacDonald, M.E. Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet.1998, 7, 1463–1474
28. Nagase, T.; Kikuno, R.; Hattori, A.; Kondo, Y.; Okumura, K.; Ohara, O. Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 2000, 7, 347–355
29. Claudio, J.O.; Liew, C.C.; Ma, J.; Heng, H.H.Q.; Stewart, A.K.; Hawley, R.G. Cloning and expression analysis of a novel WD repeat gene, WDR3, mapping to 1p12-p13. Genomics 1999, 59, 85–89
30. Iwamoto, M.; Asakawa, H.; Hiraoka, Y.; Haraguchi, T. Nucleoporin Nup98: A gatekeeper in the eukaryotic kingdoms. Genes Cells 2010, 15, 661–669
31. Tommerup, N.; Vissing, H. Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. Genomics 1995, 27, 259–264
32. Chapelin, C.; Duriez, N.; Magnino, F.; Goossens, M.; Escudier, E.; Amselem, S. Isolation of several human axonemal dynein heavy chain genes: Genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment. FEBS Lett. 1997, 412, 325–330
33. Bond, J.; Roberts, E.; Springell, K.; Lizarraga, S.B.; Scott, S.; Higgins, J.; Hampshire, D.J.; Morrison, E.E.; Leal, G.F., Silva, E.O. et al.A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat. Genet. 2005, 37, 353–355
34. Pertel, T.; Hausmann, S.; Morger, D.; Zuger, S.; Guerra, J.; Lascano, J.; Reinhard, C.; Santoni, F.A.; Uchil, P.D., Chatel, L. et al.TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472, 361–365
35. Strehl, S.; Glatt, K.; Liu, Q.M.; Glatt, H.; Lalande, M. Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics 1998, 53, 81–89
36. Miyashita, A.; Arai, H.; Asada, T.; Imagawa, M.; Matsubara, E.; Shoji, M.; Higuchi, S.; Urakami, K.; Kakita, A.; Takahashi, H. et al.Genetic association of CTNNA3 with late-onset Alzheimer’s disease in females. Hum. Mol. Genet. 2007, 16, 2854–2869
37. Kao, S.C.; Chen, C.Y.; Wang, S.L.; Yang, J.J.; Hung, W.C.; Chen, Y.C.; Lai, N.S.; Liu, H.T.; Huang, H., Chen, H.C. et al. Identification of phostensin, a PP1 F-actin cytoskeleton targeting subunit. Biochem. Biophys. Res. Commun. 2007, 356, 594–598
38. Leidinger, P.; Backes, C.; Deutscher, S.; Schmitt, K.; Mueller, S.C.; Frese, K.; Haas, J.; Ruprecht, K.; Paul, F.; Stahler, C. et al.A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013, 14, doi:10.1186/gb-2013-14-7-r78
39. Cappello, S.; Gray, M.J.; Badouel, C.; Lange, S.; Einsiedler, M.; Srour, M.; Chitayat, D.; Hamdan, F.F.; Jenkins, Z.A.; Morgan, T. et al.Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat. Genet. 2013, 45, 1300–1308
40. Grishin, A.; Li, H.; Levitan, E.S.; Zaks-Makhina, E. Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1. J. Biol. Chem. 2006, 281, 30104–30111
41. Billaut-Laden, I.; Rat, E.; Allorge, D.; Crunelle-Thibaut, A.; Cauffiez, C.; Chevalier, D.; Lo-Guidice, J.M.; Broly, F. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme. Toxicol. Lett. 2006, 165, 101–111
42. Hayette, S.; Gadoux, M.; Martel, S.; Bertrand, S.; Tigaud, I.; Magaud, J.P.; Rimokh, R. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 1998, 16, 2949–2954
43. Bajorek, M.; Morita, E.; Skalicky, J.J.; Morham, S.G.; Babst, M.; Sundquist, W.I. Biochemical analyses of human IST1 and its function in cytokinesis. Mol. Biol. Cell. 2009, 20, 1360–1373
44. Klejnot, M.; Kozielski, F. Structural insights into human Kif7, a kinesin involved in hedgehog signalling. Acta Crystallogr. 2012, 68, 154–159
45. Wu, Q.; Maniatis, T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 1999, 97, 779–790
46. Tran, T.S.; Rubio, M.E.; Clem, R.L.; Johnson, D.; Case, L.; Tessier-Lavigne, M.; Huganir, R.L.; Ginty, D.D.; Kolodkin, A.L. Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature 2009, 462, 1065–1069
47. Zhang, X.Y.; Wen, J.; Yang, W.; Wang, C.; Gao, L.; Zheng, L.H.; Wang, T.; Ran, K.; Li, Y.; Li, X. et al.Gain-of-function mutations in SCN11a cause familial episodic pain. Am. J. Hum. Genet. 2013, 93, 957–966
48. Piton, A.; Gauthier, J.; Hamdan, F.F.; Lafreniere, R.G.; Yang, Y.; Henrion, E.; Laurent, S.; Noreau, A.; Thibodeau, P.; Karemera, L. et al.Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol. Psychiatry 2011, 16, 867–880
49. Agrawal, A.; Pergadia, M.L.; Saccone, S.F.; Lynskey, M.T.; Wang, J.C.; Martin, N.G.; Statham, D.; Henders, A.; Campbell, M.; Garcia, R. et al.An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch. Gen. Psychiatry 2008, 65, 713–721
50. Yoshimura, S.; Gerondopoulos, A.; Linford, A.; Rigden, D.J.; Barr, F.A. Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. J. Cell Biol. 2010, 191, 367–381
51. Le Meur, N.; Martin, C.; Saugier-Veber, P.; Joly, G.; Lemoine, F.; Moirot, H.; Rossi, A.; Bachy, B.; Cabot, A.; Joly, P. et al.Complete germline deletion of the STK11 gene in a family with Peutz-Jeghers syndrome. Eur. J. Hum. Genet. 2004, 12, 415–418
52. Smolen, G.A.; Schott, B.J.; Stewart, R.A.; Diederichs, S.; Muir, B.; Provencher, H.L.; Look, A.T.; Sgroi, D.C.; Peterson, R.T.; Haber, D.A. A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev. 2007, 21, 2131–2136
53. Zuo, X.; Zhang, J.; Zhang, Y.; Hsu, S.C.; Zhou, D.; Guo, W. Exo70 interacts with the Arp2/3 complex and regulates cell migration. Nat. Cell Biol.2006, 8, 1383–1388
54. Oeffner, F.; Moch, C.; Neundorf, A.; Hofmann, J.; Koch, M.; Grzeschik, K.H. Novel interaction partners of Bardet-Biedl syndrome proteins. Cell Motil. Cytoskelet. 2008, 65, 143–155
55. Lopez, I.; Mak, E.C.; Ding, J.; Hamm, H.E.; Lomasney, J.W. A novel bifunctional phospholipase C that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 2001, 276, 2758–2765
56. Liefke, R.; Oswald, F.; Alvarado, C.; Ferres-Marco, D.; Mittler, G.; Rodriguez, P.; Dominguez, M.; Borggrefe, T. Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex. Genes Dev. 2010, 24, 590–601
57. Chen, P.W.; Jian, X.; Yoon, H.Y.; Randazzo, P.A. ARAP2 signals through Arf6 and Rac1 to control focal adhesion morphology. J. Biol. Chem. 2013, 288, 5849–5860
58. Chi, Z.; Zhang, J.; Tokunaga, A.; Harraz, M.M.; Byrne, S.T.; Dolinko, A.; Xu, J.; Blackshaw, S.; Gaiano, N.; Dawson, T.M. et al.Botch promotes neurogenesis by antagonizing Notch. Dev. Cell 2012, 22, 707–720
59. Tsukahara, M.; Suemori, H.; Noguchi, S.; Ji, Z.S.; Tsunoo, H. Novel nucleolar protein, midnolin, is expressed in the mesencephalon during mouse development. Gene 2000, 254, 45–55
60. Suzuki, S.; Sano, K.; Tanihara, H. Diversity of the cadherin family: Evidence for eight new cadherins in nervous tissue. Cell Regul. 1991, 2, 261–270
61. Unger, S.; Lausch, E.; Rossi, A.; Megarbane, A.; Sillence, D.; Alcausin, M.; Aytes, A.; Mendoza-Londono, R.; Nampoothiri, S.; Afroze, B. et al.Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: Congenital dislocations and vertebral changes as principal diagnostic features. Am. J. Med. Genet. A 2010, 152A, 2543–2549
62. Reimann, J.D.; Freed, E.; Hsu, J.Y.; Kramer, E.R.; Peters, J.M.; Jackson, P.K. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 2001, 105, 645–655
63. Van Der Knaap, J.A.; van Den Boom, V.; Kuipers, J.; van Eijk, M.J.; van Der Vliet, P.C.; Timmers, H.T. The gene for human TATA-binding-protein-associated factor (TAFII) 170: Structure, promoter and chromosomal localization. Biochem. J. 2000, 345, 521–527
64. Yoshiura, K.; Machida, J.; Daack-Hirsch, S.; Patil, S.R.; Ashworth, L.K.; Hecht, J.T.; Murray, J.C. Characterization of a novel gene disrupted by a balanced chromosomal translocation t(2;19)(q11.2;q13.3) in a family with cleft lip and palate. Genomics 1998, 54, 231–240
65. Kuja-Panula, J.; Kiiltomaki, M.; Yamashiro, T.; Rouhiainen, A.; Rauvala, H. AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats. J. Cell Biol. 2003, 160, 963–973
66. Dammai, V.; Subramani, S. The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol. Cell 2001, 105, 187–196
67. Iwamori, T.; Iwamori, N.; Ma, L.; Edson, M.A.; Greenbaum, M.P.; Matzuk, M.M. TEX14 interacts with CEP55 to block cell abscission. Mol. Cell. Biol.2010, 30, 2280–2292
68. Friedman, J.R.; Kaestner, K.H. The Foxa family of transcription factors in development and metabolism. Cell Mol. Life Sci. 2006, 63, 2317–2328
69. Yoon, D.; Kim, Y.J.; Cui, W.Y.; Van der Vaart, A.; Cho, Y.S.; Lee, J.Y.; Ma, J.Z.; Payne, T.J.; Li, M.D.; Park, T. Large-scale genome-wide association study of asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence. Hum. Genet. 2012, 131, 1009–1021
70. Licciulli, S.; Cambiaghi, V.; Scafetta, G.; Gruszka, A.M.; Alcalay, M. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation. Leukemia 2010, 24, 429–437
71. Pazour, G.J.; Agrin, N.; Walker, B.L.; Witman, G.B. Identification of predicted human outer dynein arm genes: Candidates for primary ciliary dyskinesia genes. J. Med. Genet.2006, 43, 62–73
72. Chou, S.J.; O’Leary, D.D. Role for Lhx2 in corticogenesis through regulation of progenitor differentiation. Mol. Cell. Neurosci. 2013, 56, 1–9
73. Leighton, P.A.; Mitchell, K.J.; Goodrich, L.V.; Lu, X.; Pinson, K.; Scherz, P.; Skarnes, W.C.; Tessier-Lavigne, M. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 2001, 410, 174–179
74. Piton, A.; Michaud, J.L.; Peng, H.; Aradhya, S.; Gauthier, J.; Mottron, L.; Champagne, N.; Lafreniere, R.G.; Hamdan, F.F.; team, S.D. et al.Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 2008, 17, 3965–3974
75. Sinibaldi, L.; De Luca, A.; Bellacchio, E.; Conti, E.; Pasini, A.; Paloscia, C.; Spalletta, G.; Caltagirone, C.; Pizzuti, A.; Dallapiccola, B. Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum. Mutat. 2004, 24, 534–535
76. Ono, Y.; Ohno, M.; Shimura, Y. Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22. Mol. Cell. Biol. 1994, 14, 7611–7620
77. Katoh, Y.; Katoh, M. Comparative integromics on FAT1, FAT2, FAT3 and FAT4. Int. J. Mol. Med. 2006, 18, 523–528
78. Neale, B.M.; Kou, Y.; Liu, L.; Ma'ayan, A.; Samocha, K.E.; Sabo, A.; Lin, C.F.; Stevens, C.; Wang, L.S.; Makarov, V. et al.Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485, 242–245
79. Kenny, E.M.; Cormican, P.; Furlong, S.; Heron, E.; Kenny, G.; Fahey, C.; Kelleher, E.; Ennis, S.; Tropea, D.; Anney, R. et al.Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry 2014, 19, 872–879
80. Kadereit, B.; Kumar, P.; Wang, W.J.; Miranda, D.; Snapp, E.L.; Severina, N.; Torregroza, I.; Evans, T.; Silver, D.L. Evolutionarily conserved gene family important for fat storage. Proc. Natl. Acad. Sci. USA 2008, 105, 94–99
81. Bai, S.W.; Herrera-Abreu, M.T.; Rohn, J.L.; Racine, V.; Tajadura, V.; Suryavanshi, N.; Bechtel, S.; Wiemann, S.; Baum, B.; Ridley, A.J. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration. BMC Biol. 2011, 9, 54
82. Liu, F.; Arias-Vasquez, A.; Sleegers, K.; Aulchenko, Y.S.; Kayser, M.; Sanchez-Juan, P.; Feng, B.J.; Bertoli-Avella, A.M.; van Swieten, J.; Axenovich, T.I. et al.A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am. J. Hum. Genet. 2007, 81, 17–31
83. Jin, J.; Smith, F.D.; Stark, C.; Wells, C.D.; Fawcett, J.P.; Kulkarni, S.; Metalnikov, P.; O’Donnell, P.; Taylor, P.; Taylor, L. et al.Proteomic, functional, and domain-based analysis of in vivo 14–3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 2004, 14, 1436–1450
84. Kile, B.T.; Viney, E.M.; Willson, T.A.; Brodnicki, T.C.; Cancilla, M.R.; Herlihy, A.S.; Croker, B.A.; Baca, M.; Nicola, N.A.; Hilton, D.J. et al.Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins asb-1, asb-2, asb-3 and asb-4. Gene 2000, 258, 31–41
85. Dodge-Kafka, K.L.; Soughayer, J.; Pare, G.C.; Michel, J.J.C.; Langeberg, L.K.; Kapiloff, M.S.; Scott, J.D. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437, 574–578
86. Wu, S.; Wright, R.A.; Rockey, P.K.; Burgett, S.G.; Arnold, J.S.; Rosteck, P.R., Jr.; Johnson, B.G.; Schoepp, D.D.; Belagaje, R.M. Group III human metabotropic glutamate receptors 4, 7 and 8: Molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells. Brain Res. Mol. Brain Res. 1998, 53, 88–97
87. Berbari, N.F.; Kin, N.W.; Sharma, N.; Michaud, E.J.; Kesterson, R.A.; Yoder, B.K. Mutations in Traf3ip1 reveal defects in ciliogenesis, embryonic development, and altered cell size regulation. Dev. Biol. 2011, 360, 66–76
88. Davis, B.N.; Hilyard, A.C.; Lagna, G.; Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454, 56–61
89. Goizet, C.; Boukhris, A.; Mundwiller, E.; Tallaksen, C.; Forlani, S.; Toutain, A.; Carriere, N.; Paquis, V.; Depienne, C.; Durr, A. et al.Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum. Mutat. 2008, 30, E376–E385
90. Youngs, E.L.; Hellings, J.A.; Butler, M.G. ANKRD11 gene deletion in a 17-year-old male. Clin. Dysmorphol. 2011, 20, 170–171
91. Sirmaci, A.; Spiliopoulos, M.; Brancati, F.; Powell, E.; Duman, D.; Abrams, A.; Bademci, G.; Agolini, E.; Guo, S.; Konuk, B. et al.Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. Am. J. Hum. Genet. 2011, 89, 289–294
92. Mi, S.; Lee, X.; Hu, Y.; Ji, B.; Shao, Z.; Yang, W.; Huang, G.; Walus, L.; Rhodes, K.; Gong, B.J. et al.Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination. Nat. Med. 2011, 17, 816–821
93. Guernsey, D.L.; Jiang, H.; Bedard, K.; Evans, S.C.; Ferguson, M.; Matsuoka, M.; Macgillivray, C.; Nightingale, M.; Perry, S.; Rideout, A.L. et al.Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease. PLoS Genet. 2010, 6, doi:10.1371/journal.pgen.1001081
94. Weterman, M.A.; Sorrentino, V.; Kasher, P.R.; Jakobs, M.E.; van Engelen, B.G.; Fluiter, K.; de Wissel, M.B.; Sizarov, A.; Nurnberg, G.; Nurnberg, P. et al.A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy. Hum. Mol. Genet.2012, 21, 358–370
95. Burnside, R.D.; Pasion, R.; Mikhail, F.M.; Carroll, A.J.; Robin, N.H.; Youngs, E.L.; Gadi, I.K.; Keitges, E.; Jaswaney, V.L.; Papenhausen, P.R. et al.Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delay. Hum. Genet. 2011, 130, 517–528
96. Pastuszak, I.; Ketchum, C.; Hermanson, G.; Sjoberg, E.J.; Drake, R.; Elbein, A.D. GDP-L-fucose pyrophosphorylase. Purification, cDNA cloning, and properties of the enzyme. J. Biol. Chem. 1998, 273, 30165–30174
97. Xu, C.; Li, P.P.; Cooke, R.G.; Parikh, S.V.; Wang, K.; Kennedy, J.L.; Warsh, J.J. TRPM2 variants and bipolar disorder risk: Confirmation in a family-based association study. Bipolar Disord. 2009, 11, 1–10
98. Bueno, M.T.; Richard, S. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Epigenetics 2013, 8, 1162–1175
99. Catchpole, S.; Spencer-Dene, B.; Hall, D.; Santangelo, S.; Rosewell, I.; Guenatri, M.; Beatson, R.; Scibetta, A.G.; Burchell, J.M.; Taylor-Papadimitriou, J. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells. Int. J. Oncol.2011, 38, 1267–1277
100. Carmona-Mora, P.; Walz, K. Retinoic acid induced 1, RAI1: A dosage sensitive gene related to neurobehavioral alterations including autistic behavior. Curr. Genomics 2010, 11, 607–617
101. Van Wijk, S.J.; Timmers, H.T. The family of ubiquitin-conjugating enzymes (E2s): Deciding between life and death of proteins. FASEB J. 2010, 24, 981–993
102. Kirchmair, R.; Hogue-Angeletti, R.; Gutierrez, J.; Fischer-Colbrie, R.; Winkler, H. Secretoneurin—A neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 1993, 53, 359–365
103. Tanji, K.; Kamitani, T.; Mori, F.; Kakita, A.; Takahashi, H.; Wakabayashi, K. TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies. Neurobiol. Dis. 2010, 38, 210–218
104. Takash, W.; Canizares, J.; Bonneaud, N.; Poulat, F.; Mattei, M.G.; Jay, P.; Berta, P. SOX7 transcription factor: Sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res. 2001, 29, 4274–4283
105. Agrawal, A.; Lynskey, M.T.; Hinrichs, A.; Grucza, R.; Saccone, S.F.; Krueger, R.; Neuman, R.; Howells, W.; Fisher, S.; Fox, L. et al.A genome-wide association study of DSM-IV cannabis dependence. Addict. Biol.2011, 16, 514–518
106. Kokura, K.; Sun, L.; Bedford, M.T.; Fang, J. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J. 2010, 29, 3673–3687
107. Bonnert, T.P.; McKernan, R.M.; Farrar, S.; le Bourdelles, B.; Heavens, R.P.; Smith, D.W.; Hewson, L.; Rigby, M.R.; Sirinathsinghji, D.J.; Brown, N. et al.Theta, a novel γ-aminobutyric acid type a receptor subunit. Proc. Natl. Acad. Sci. USA 1999, 96, 9891–9896
108. Kobayashi, K.; Kuroda, S.; Fukata, M.; Nakamura, T.; Nagase, T.; Nomura, N.; Matsuura, Y.; Yoshida-Kubomura, N.; Iwamatsu, A.; Kaibuchi, K. P140Sra-1 (specifically rac1-associated protein) is a novel specific target for rac1 small GTPase. J. Biol. Chem. 1998, 273, 291–295
109. Schenck, A.; Bardoni, B.; Moro, A.; Bagni, C.; Mandel, J.L. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with fmrp-related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. USA 2001, 98, 8844–8849
110. Yang, Y.; Muzny, D.M.; Xia, F.; Niu, Z.; Person, R.; Ding, Y.; Ward, P.; Braxton, A.; Wang, M.; Buhay, C. et al.Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014, 312, 1870–1879.